DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 1 filers reported holding DICERNA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $226,000 | -46.1% | 11,235 | 0.0% | 0.00% | -50.0% |
Q2 2021 | $419,000 | +0.7% | 11,235 | -31.0% | 0.00% | -33.3% |
Q1 2021 | $416,000 | +77.0% | 16,283 | +52.9% | 0.00% | +50.0% |
Q4 2020 | $235,000 | +55.6% | 10,648 | +27.1% | 0.00% | +100.0% |
Q3 2020 | $151,000 | -32.0% | 8,378 | -4.1% | 0.00% | -66.7% |
Q2 2020 | $222,000 | +65.7% | 8,739 | +19.7% | 0.00% | +50.0% |
Q1 2020 | $134,000 | +9.8% | 7,303 | +26.9% | 0.00% | 0.0% |
Q4 2019 | $122,000 | -31.1% | 5,756 | -53.4% | 0.00% | -33.3% |
Q3 2019 | $177,000 | +12.7% | 12,340 | +23.8% | 0.00% | 0.0% |
Q2 2019 | $157,000 | -7.6% | 9,966 | -14.2% | 0.00% | -25.0% |
Q1 2019 | $170,000 | +46.6% | 11,618 | +8.9% | 0.00% | +33.3% |
Q4 2018 | $116,000 | -27.5% | 10,673 | +1.6% | 0.00% | 0.0% |
Q3 2018 | $160,000 | – | 10,510 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aquilo Capital Management, LLC | 1,705,392 | $43,607,000 | 7.88% |
Bain Capital Life Sciences Investors, LLC | 3,080,237 | $78,762,000 | 4.46% |
DAFNA Capital Management LLC | 587,756 | $15,029,000 | 3.57% |
RTW INVESTMENTS, LP | 7,463,291 | $190,836,000 | 2.98% |
SILVERARC CAPITAL MANAGEMENT, LLC | 200,000 | $5,114,000 | 2.79% |
Evolutionary Tree Capital Management, LLC | 122,473 | $3,132,000 | 1.85% |
Parkman Healthcare Partners LLC | 303,268 | $7,755,000 | 1.80% |
Eagle Health Investments LP | 161,125 | $4,120,000 | 1.62% |
BRIDGER MANAGEMENT, LLC | 588,910 | $15,058,000 | 1.41% |
Woodline Partners LP | 1,777,000 | $45,438,000 | 1.01% |